American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PolyPid Ltd. (PYPD)

$3.90 -8.02% NASDAQ: PYPD · 15-min delayed

Public · NASDAQ: PYPD
75 employees

Visit website Follow

$86.3MMarket cap

-$34.2MNet income

75Employees

PYPDNASDAQ

2020IPO

About PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: PYPD
Employees: 75
IPO date: Jun 26, 2020
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: PYPD Nasdaq
SEC CIK: 1611842
SIC: 3841 Surgical & Medical Instruments & Apparatus

Embed this company’s badge

Show PolyPid Ltd.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/polypid-ltd/"><img src="https://americancompanies.com/badge/polypid-ltd.svg" alt="PolyPid Ltd. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow PolyPid Ltd. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: -$34.2M
Total assets: $22.3M
Market cap: $86.3M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: PYPD

$3.90 -8.02%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.15 $5.58

52-week range

Market cap: $86.3M
Shares outstanding: 22.1M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jun 26, 2020

PolyPid Ltd. (PYPD) Stock Price

Reported a net loss of $34.2M.
Trading 30% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review PolyPid Ltd..

Write a review

Newsroom

News about PolyPid Ltd.

PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026 GlobeNewswire Inc. · 2026-01-28 · positive PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results GlobeNewswire Inc. · 2025-06-16 · positive PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference GlobeNewswire Inc. · 2025-01-30 · positive PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025 GlobeNewswire Inc. · 2025-01-29 · positive PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million GlobeNewswire Inc. · 2024-12-24 · positive PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance GlobeNewswire Inc. · 2024-11-29 · neutral

News & sentiment via Polygon.io

FAQ

PolyPid Ltd.: frequently asked questions

Is PolyPid Ltd. an American company?

PolyPid Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is PolyPid Ltd. publicly traded?

Yes — PolyPid Ltd. is a publicly traded company. Its stock trades under the ticker symbol PYPD on the NASDAQ.

What does PolyPid Ltd. do?

PolyPid Ltd. is an American Medical Devices company in the Health & Beauty sector.

Explore